Risk factors for consequent kidney impairment and differential impact of liver transplantation on renal function

被引:53
作者
Lee, Jung Pyo [1 ]
Heo, Nam Ju [2 ]
Joo, Kwon Wook [2 ]
Yi, Nam Joon [3 ]
Suh, Kyung-Suk [3 ]
Moon, Kyung Chul [4 ]
Kim, Seong Gyun [5 ]
Kim, Yon Su [1 ,2 ]
机构
[1] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 151, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea
[5] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea
关键词
calcineurin inhibitor toxicity; hepatitis B virus; kidney biopsy; kidney dysfunction; liver transplantation; HEPATORENAL-SYNDROME; SERUM CREATININE; NATURAL-HISTORY; DYSFUNCTION; DISEASE; CYCLOSPORINE; FAILURE; TACROLIMUS; GFR;
D O I
10.1093/ndt/gfq093
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Chronic kidney disease (CKD) develops frequently after liver transplantation (LTx), and it is important to identify and correct risk factors that negatively affect kidney function. Risk factors have not been well evaluated in Asian countries where hepatitis B virus (HBV) infection is a dominant cause. Methods. Four hundred thirty-one Korean recipients who underwent LTx between 1997 and 2008 were analysed. CKD was defined as a sustained decrease in estimated glomerular filtration rate (eGFR) of < 60 (mL/min/1.73 m(2)) for at least three consecutive months using an abbreviated Modification in Renal Disease (MDRD) formula. Results. Eighty percent of the patients had HBV-related underlying diseases. The recipients whose pretransplant eGFR had been low (< 30 mL/min/1.73 m(2)) improved their renal function after LTx, but significant functional decline occurred in recipients whose pretransplant eGFR was high (>= 60 mL/min/1.73 m(2)). A multivariate Cox regression analysis revealed that the overall risk of CKD development (eGFR < 60 mL/min/1.73 m(2)) was associated with old age of recipients, cyclosporine, posttransplant acute renal failure (ARF), cause [calcineurin inhibitor (CNI) nephrotoxicity] and severity of posttransplant ARF, low pretransplant eGFR, pretransplant hepatorenal syndrome, pretransplant proteinuria, high Child Pugh score and high Model for End-Stage Renal Disease (MELD) score. Especially in recipients whose pre-operative eGFR was high (>= 60 mL/min/1.73 m(2)), rapid progression of kidney disease was associated with high tacrolimus level, non-HBV disease, posttransplant ARF, cause (CNI nephrotoxicity) and severity of posttransplant ARF and Child-Pugh score. CNI toxicity and focal segmental sclerosis, but not immune-complex disease, were revealed as significant contributors to CKD after LTx in HBV recipients. Conclusion. Judicious use of CNIs should be applied to liver recipients to prevent kidney dysfunction.
引用
收藏
页码:2772 / 2785
页数:14
相关论文
共 33 条
[1]   The natural history of renal function following orthotopic heart transplant [J].
Al Aly, Z ;
Abbas, S ;
Moore, E ;
Diallo, O ;
Hauptman, PJ ;
Bastani, B .
CLINICAL TRANSPLANTATION, 2005, 19 (05) :683-689
[2]   MELD score and clinical type predict prognosis in hepatorenal syndrome:: Relevance to liver transplantation [J].
Alessandria, C ;
Ozdogan, O ;
Guevara, M ;
Restuccia, T ;
Jiménez, W ;
Arroyo, V ;
Rodés, J ;
Ginès, P .
HEPATOLOGY, 2005, 41 (06) :1282-1289
[3]   Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [J].
Arroyo, V ;
Gines, P ;
Gerbes, AL ;
Dudley, FJ ;
Gentilini, P ;
Laffi, G ;
Reynolds, TB ;
RingLarsen, H ;
Scholmerich, J .
HEPATOLOGY, 1996, 23 (01) :164-176
[4]   Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus [J].
Artz, MA ;
Boots, JMM ;
Ligtenberg, G ;
Roodnat, JI ;
Christiaans, MHL ;
Vos, PF ;
Blom, HJ ;
Sweep, FCGJ ;
Demacker, PNM ;
Hilbrands, LB .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07) :1880-1888
[5]   Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].
Bellomo, R ;
Ronco, C ;
Kellum, JA ;
Mehta, RL ;
Palevsky, P .
CRITICAL CARE, 2004, 8 (04) :R204-R212
[6]  
BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110
[7]   Risk factors of acute renal failure after liver transplantation [J].
Cabezuelo, JB ;
Ramírez, P ;
Ríos, A ;
Acosta, F ;
Torres, D ;
Sansano, T ;
Pons, JA ;
Bru, M ;
Montoya, M ;
Bueno, FS ;
Robles, R ;
Parrilla, P .
KIDNEY INTERNATIONAL, 2006, 69 (06) :1073-1080
[8]  
Campistol JM, 2000, TRANSPLANTATION, V69, pSS5
[9]   Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients - assessment of renal and allograft function, cardiovascular risk factors and immune monitoring [J].
Cicinnati, V. R. ;
Yu, Z. ;
Klein, C. G. ;
Sotiropoulos, G. C. ;
Saner, F. ;
Malago, M. ;
Frilling, A. ;
Gerken, G. ;
Broelsch, C. E. ;
Beckebaum, S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (09) :1195-1208
[10]   Chronic renal dysfunction late after liver transplantation [J].
Cohen, AJ ;
Stegall, MD ;
Rosen, CB ;
Wiesner, RH ;
Leung, N ;
Kremers, WK ;
Zein, NN .
LIVER TRANSPLANTATION, 2002, 8 (10) :916-921